Results 1-10 of approx. 449

Isis Pharmaceuticals Inc. (ISIS) Stock Quote

Get the latest ISIS - Isis Pharmaceuticals Inc. stock market performance data and financial news.

http://www.thestreet.com/quote/ISIS.html

Isis Cholesterol Drug Effective, but Safety a Worry: BioBuzz ...

By Adam Feuerstein 11/17/09

Mipomersen lowers cholesterol but not without liver side effects.. Check out TheStreet for the latest stock market news and financial investment headlines.

http://www.thestreet.com/story/10627796/1/isis-cholesterol-drug-effective-but-safety-a-worry-biobuzz.html

Isis Pharmaceuticals Adds Two New Drugs To Development Pipeline ...

By PR Newswire 12/03/09

ISIS-FXIRx to Treat Clotting Disorders. Check out TheStreet for the latest stock market news and financial investment headlines.

http://www.thestreet.com/story/10637593/1/isis-pharmaceuticals-adds-two-new-drugs-to-development-pipeline.html

Health Winners & Losers: Isis

By Elizabeth Trotta 05/27/08

Isis climbs on news it will benefit financially from a deal between Alnylam and Takeda.. Check out TheStreet for the latest stock market news and financial investment headlines.

http://www.thestreet.com/story/10418548/1/health-winners-losers-isis.html

Isis Pharmaceuticals (Nasdaq: ISIS) Letter To Shareholders

By PR Newswire 11/23/09

. Check out TheStreet for the latest stock market news and financial investment headlines.

http://www.thestreet.com/story/10630766/1/isis-pharmaceuticals-nasdaq-isis-letter-to-shareholders.html

Genzyme And Isis Say Cholesterol Drug Met Goal

By The Associated Press 05/20/09

Cholesterol drug mipomersen reached main goal in late stage trial, Isis and Genzyme say. Check out TheStreet for the latest stock market news and financial investment headlines.

http://www.thestreet.com/story/10503544/1/genzyme-and-isis-say-cholesterol-drug-met-goal.html

Health Winners & Losers: Isis

By Elizabeth Trotta 05/12/08

The biotech rises on a narrowed first-quarter loss.. Check out TheStreet for the latest stock market news and financial investment headlines.

http://www.thestreet.com/story/10416406/1/health-winners-losers-isis.html

RealMoney.com: Genzyme-Isis Deal Detailed

Genzyme-Isis Deal Detailed, Details from an SEC filing reveal the
licensing pact for mipomersen may not be overly pricey. ...

http://www.thestreet.com/p/newsanalysis/biotech/10397798.html

RealMoney.com: How Mighty Is Isis?

How Mighty Is Isis?, The biotech soars on promising drug results, but can its
fundamentals endure? ... Print This Story. How Mighty Is Isis? ...

http://www.thestreet.com/p/newsanalysis/investing/10322093.html

More From TheStreet

Latest Headlines

Brokerage Partners

TheStreet Premium Services

All Services